Oral submucous fibrosis: Histopathological features with pathophysiologic correlations

Sanpreet Singh Sachdev; Yogita Bhaginath Adhane; Manisha Ahire Sardar; Tabita Joy Chettiankandy; Sarang Gautam Sonawane

doi:10.18231/j.jdpo.2021.045

journal article Sep 15, 2021

Oral submucous fibrosis: Histopathological features with pathophysiologic correlations

Sanpreet Singh Sachdev

Yogita Bhaginath Adhane Manisha Ahire Sardar

Tabita Joy Chettiankandy

Sarang Gautam Sonawane

IP Journal of Diagnostic Pathology and Oncology Vol. 6 No. 3 pp. 211-215 · IP Innovative Publication Pvt Ltd

View at Publisher Save 10.18231/j.jdpo.2021.045

Abstract

Oral submucous fibrosis (OSMF) is a potentially malignant disorder characterized by juxtaepithelial inflammation and progressive fibrosis of submucosal tissues. It may affect any part of the oral cavity, as well as pharynx and oesophagus. The pathogenesis of OSMF may be attributable to habitual chewing of areca nut and its products, which is more prevalent amongst young population of South East Asia and India. Various histopathological features in different tissue components- epithelial, connective tissue stroma, muscle and salivary gland may be observed along the course of this chronic disorder. In connective tissue, extensive fibrosis with progressive hyalinization of collagen fibers and muscles accompanied by inflammatory response is considered to be pathognomonic feature. Advanced stages of OSMF may show atrophic changes or even dysplasia in the epithelium which may undergo malignant transformation. Malignant transformation rate of OSMF has been proved to be around 7.5%. Thus, identification of early histopathological changes in OSMF can lead to improved survival rates. The present article illustrates the various histopathological features observed during different stages of development of OSMF. A better understanding of the correlation between histopathological features and corresponding clinical manifestations can aid dental surgeons in prognostication of the lesion and determining response to treatment.

Topics

No keywords indexed for this article. Browse by subject →

References

30

[1]

Celik N, Wei F C, Chang Y M, Yang W G, Chen D J, Tsai C Y, Squamous cell carcinoma of the oral mucosa after release of submucous fibrosis and bilateral small radial forearm flap reconstruction.Plast Reconstr Surg 2002;110(1):34-8 10.1097/00006534-200207000-00008

[2]

Sivapathasundharam B, Rajendran R, Premalignant’ Lesions/Condition of Epithelial Tissue Origin.Shafer's Textbook of Oral Pathology. 8th Edn..136-50

[3]

Rajendran R, Oral submucous fibrosis.J Oral Maxillofac Pathol 2003;7(1):1-4 10.4103/0973-029x.40996

[4]

S Warnakulasuriya, WM Tilakaratne, Potentially Malignant Disorders.Oral medicine & pathology: a guide to diagnosis and management. 1st Edn..268-97

[5]

Pindborg J J, Sirsat S M, Oral submucous fibrosis.Oral Surg Oral Med Oral Pathol 1966;22(6):764-79 10.1016/0030-4220(66)90367-7

[6]

Kumar K K, Saraswathi T R, Ranganathan K, Devi M U, Elizabeth J, Oral submucous fibrosis: A clinico-histopathological study in Chennai.Indian J Dent Res 2007;18(3):106 10.4103/0970-9290.33785

[7]

Singh A, Ladusingh L, Prevalence and determinants of tobacco use in India: evidence from recent Global Adult Tobacco Survey data.PloS One 2014;9(12):114073 10.1371/journal.pone.0114073

[8]

10.1136/bmjopen-2020-043987

[9]

10.1016/j.oooo.2015.11.024

[10]

WHO. Meeting report. Control of oral cancer in developing countries. WHO Bull. 1984;62:617

[11]

Mehrotra R, Gupta A, Singh M, Ibrahim R, Application of cytology and molecular biology in diagnosing premalignant or malignant oral lesions.Mol Cancer 2006;5(1):1-9 10.1186/1476-4598-5-11

[12]

10.4103/jcrt.jcrt_522_17

[13]

10.1186/1758-3284-1-10

[14]

Tilakaratne W M, Ekanayaka R P, Herath M, Jayasinghe R D, Sitheeque M, Amarasinghe H, Intralesional corticosteroidsas a treatment for restricted mouth opening in oral submucous fibrosis.Oral Surg Oral Med Oral Pathol Oral Radiol 2016;122(2):224-31 10.1016/j.oooo.2015.11.023

[15]

Isaac U, Issac J S, Khoso N A, Histopathologic features of oral submucous fibrosis: a study of 35 biopsy specimens.Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;106(4):556-60 10.1016/j.tripleo.2006.11.045

[16]

10.3390/ijms20122940

[17]

Haque M F, Harris M, Meghji S, Barrett A W, Immunolocalization of cytokines and growth factors in oral submucous fibrosis.Cytokine 1998;10(9):713-9 10.1006/cyto.1997.0342

[18]

Utsunomiya H, Tilakaratne W M, Oshiro K, Maruyama S, Suzuki M, Ida-Yonemochi H, Extracellular matrix remodelingin oral submucous fibrosis: Its stage-specific modes revealed by immunohistochemistry and in situ hybridization.J Oral Pathol Med 2005;34(8):498-507 10.1111/j.1600-0714.2005.00339.x

[19]

Murgod V V, Kale A D, Angadi P V, Hallikerimath S, Morphometric analysis of the mucosal vasculature in oral submucous fibrosis and its comparison with oral squamous cell carcinoma.J Oral Sci 2014;56(2):173-8 10.2334/josnusd.56.173

[20]

10.4103/0970-9290.29909

[21]

Auluck A, Rosin M P, Zhang L, Sumanth K N, Oral submucous fibrosis, a clinically benign but potentially malignant disease: report of 3 cases and review of the literature.J Can Dent Assoc 2008;74(8):735-40

[22]

Nyachhyon R, Boaz K, Sumanth K N, Minor salivary gland changes in oral submucous fi brosis (OSMF): Retrospective pilot study.J Nepal Dent Assoc 2011;12(1):26-8

[23]

Rajendran R, Varkey S, Inducible nitric oxide synthase expression is upregulated in oral submucous fibrosis.Indian J Dent Res 2007;18(3):94-100 10.4103/0970-9290.33783

[24]

Rangaswamy S, Chikkalingaiah R G, Sanjeevarayappa P N, Govindraju P, Carcinoma arising in the background of oral submucous fibrosis.Ann Maxillofac Surg 2019;9(2):247 10.4103/ams.ams_280_18

[25]

10.1371/journal.pone.0200171

[26]

Jayasooriya PR, Jayasinghe KA Nadeeka, Tilakaratne WM, , Relationship between thickness of fibrosis and epithelial dysplasia in oral submucous fibrosis.J Invest Clin Dent 2011;2(3):171-5 10.1111/j.2041-1626.2011.00055.x

[27]

Arakeri G, Patil S G, Aljabab A S, Lin K C, Merkx M A, Gao S, Oral submucous fibrosis: an update on pathophysiology of malignant transformation.J Oral Pathol Med 2017;46(6):413-7 10.1111/jop.12582

[28]

Murti P R, Bhonsle R B, Pindborg J J, Daftary D K, Gupta P C, Mehta F S, Malignant transformation rate in oral submucous fibrosis over a17-yr period.Community Dent Oral Epidemol 1985;13(6):340-1 10.1111/j.1600-0528.1985.tb00468.x

[29]

Pindborg J J, Oral submucous fibrosis: a review.Ann Acad Med Singapore 1989;18(5):603-7 10.1111/j.1600-0714.1989.tb00721.x

[30]

Sarode SC, Sarode GS, Better grade of tumor differentiation of oral squamous cell carcinoma arising in background of oral submucous fibrosis.Med Hypotheses 2013;81(4):540-3 10.1016/j.mehy.2013.07.001

Metrics

3

Citations

30

References

Details

Published: Sep 15, 2021
Vol/Issue: 6(3)
Pages: 211-215

Authors

S

Sanpreet Singh Sachdev

G

Y

Yogita Bhaginath Adhane

Govt. Dental College and Hospital, Mumbai, Maharashtra, India

M

Manisha Ahire Sardar

Government Dental College & Hospital, Mumbai, Maharashtra, India

T

Tabita Joy Chettiankandy

S

Sarang Gautam Sonawane

Cite This Article

Sanpreet Singh Sachdev, Yogita Bhaginath Adhane, Manisha Ahire Sardar, et al. (2021). Oral submucous fibrosis: Histopathological features with pathophysiologic correlations. IP Journal of Diagnostic Pathology and Oncology, 6(3), 211-215. https://doi.org/10.18231/j.jdpo.2021.045

Oral submucous fibrosis: Histopathological features with pathophysiologic correlations

You May Also Like